These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11747902)
1. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523. Tottori K; Miwa T; Uwahodo Y; Yamada S; Nakai M; Oshiro Y; Kikuchi T; Altar CA Neuropharmacology; 2001 Dec; 41(8):976-88. PubMed ID: 11747902 [TBL] [Abstract][Full Text] [Related]
2. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus. Bermack JE; Haddjeri N; Debonnel G J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate). Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors. Tordera RM; Monge A; Del Río J; Lasheras B Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683 [TBL] [Abstract][Full Text] [Related]
5. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors. Bermack JE; Debonnel G J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864 [TBL] [Abstract][Full Text] [Related]
6. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549 [TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats. Skuza G; Rogóz Z Pharmacol Rep; 2007; 59(6):773-7. PubMed ID: 18195469 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Rogóz Z; Skuza G Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794 [TBL] [Abstract][Full Text] [Related]
10. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438 [TBL] [Abstract][Full Text] [Related]
11. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation. Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317 [TBL] [Abstract][Full Text] [Related]
12. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors. Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119 [TBL] [Abstract][Full Text] [Related]
13. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Jordan S; Koprivica V; Chen R; Tottori K; Kikuchi T; Altar CA Eur J Pharmacol; 2002 Apr; 441(3):137-40. PubMed ID: 12063084 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. Bourin M; Mocaër E; Porsolt R J Psychiatry Neurosci; 2004 Mar; 29(2):126-33. PubMed ID: 15069466 [TBL] [Abstract][Full Text] [Related]
15. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Estrada-Camarena E; Fernández-Guasti A; López-Rubalcava C Neuropsychopharmacology; 2006 Feb; 31(2):247-55. PubMed ID: 16012533 [TBL] [Abstract][Full Text] [Related]
16. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test. Miyata S; Hirano S; Kamei J Neuropsychopharmacology; 2004 Mar; 29(3):461-9. PubMed ID: 14628002 [TBL] [Abstract][Full Text] [Related]
17. Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist. Romero L; Celada P; Martín-Ruiz R; Díaz-Mataix L; Mourelle M; Delgadillo J; Hervás I; Artigas F Neuropsychopharmacology; 2003 Mar; 28(3):445-56. PubMed ID: 12629524 [TBL] [Abstract][Full Text] [Related]
18. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test. Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477 [TBL] [Abstract][Full Text] [Related]
19. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice. Clenet F; De Vos A; Bourin M Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT Gu ZS; Xiao Y; Zhang QW; Li JQ Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]